# NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)

> **NCT00322465** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 305 (actual)

## Conditions studied

- Urethritis

## Interventions

- **DRUG:** Tinidazole
- **OTHER:** Placebo
- **DRUG:** Doxycycline
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00322465
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2019-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322465, "NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00322465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*